List of works - Bruce C Carleton

A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose

scientific article published on 13 March 2015

A case study examining the impacts of conferencing technologies in distributed healthcare groups

article

A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.

scientific article

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

scientific article

A simpler approach to pharmacokinetic dosage adjustments.

scientific article published on November 1997

A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children

scientific article published on March 21, 2011

Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial

scientific article published in July 2018

Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

scientific article

An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration

scientific article

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.

scientific article published on 22 December 2017

Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database

scientific article published on 19 November 2018

Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review

scientific article published on 01 October 2018

Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.

scientific article published in December 2012

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia

scientific article published on 2 June 2017

Application of principal component analysis to pharmacogenomic studies in Canada

article

Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study

scientific article published on 16 April 2018

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.

scientific article published on 27 April 2017

Association between regulatory advisories and codeine prescribing to postpartum women

scientific article published in May 2015

Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study

scientific article published on 01 August 2018

Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema

scientific article

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery

scientific article published on 16 March 2017

Asthma in British Columbia: Are we finally breathing easier? A population-based study of the burden of disease over 14 years.

scientific article published on 14 July 2016

Beta-blocker use and COPD mortality: a systematic review and meta-analysis

scientific article

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

scientific article published on 08 November 2018

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.

scientific article

Camouflaged sampling and contacting of people from administrative databases: reaching target patients without knowing who they are.

scientific article published in August 2008

Cancer pharmacogenomics in children: research initiatives and progress to date.

scientific article published on April 2013

Cases: Cocaine adulterant linked to neutropenia

scientific article

Central Nervous System Depression of Neonates Breastfed by Mothers Receiving Oxycodone for Postpartum Analgesia

scientific article published on 31 August 2011

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

scientific article published on 18 August 2014

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

scientific article published on 2 February 2018

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

scientific article

Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

scientific article published on 24 February 2004

Codeine-related deaths: The role of pharmacogenetics and drug interactions

scientific article published on 26 March 2014

Comment: cost of rhDNase in cystic fibrosis

scientific article

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

scientific article published on 16 July 2018

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.

scientific article

Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS)

article

Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.

scientific article published on December 2010

Dentists’ Prescribing of Analgesics for Children in British Columbia, Canada

scientific article published in August 2017

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study

scientific article published on 16 February 2017

Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations

scientific article published in October 2007

Development of a broad-based ADME panel for use in pharmacogenomic studies

scientific article published on June 2014

Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe

scientific article published on 05 July 2011

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

scientific article published on 18 January 2011

Drug and poison information resources on the Internet, Part 1: An introduction

scientific article published on 01 July 1996

Drug formulary decision-making in two regional health authorities in British Columbia, Canada

scientific article

Economic impact of a genetic test for cisplatin-induced ototoxicity

scientific article published on 19 April 2011

Effects and ethics of sanctions on childhood immunization rates

scientific article published on 01 October 2000

Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy

scientific article published on 01 February 1993

Emergency department visits for children with acute asthma: discharge instructions, parental plans, and follow-through of care--a prospective study.

scientific article published on November 2014

Evidence-Based Pharmacotherapy: Review of Basic Concepts and Applications in Clinical Practice

article

Exome sequencing pilot study in children with carbamazepine-induced serious skin reactions

scientific article

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.

scientific article

Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources?

scientific article

Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study

scientific article published in 2017

Formulas containing live probiotic bacteria

article

From professional advocacy to patient advocacy: a gambit for pharmacists

scientific article published on 01 January 2001

Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients

scientific article published on 22 January 2018

Gene-based warfaring dosing

scientific article published in June 2010

Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study

scientific article published on 19 March 2019

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

scientific article published on 27 September 2018

Genetic determinants of cocaine-associated agranulocytosis.

scientific article published on 13 June 2015

Genetic determinants of ototoxicity during and after childhood cancer treatment: design of PanCareLIFE studies (Preprint)

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

scientific article

Genetic markers of cisplatin-induced hearing loss in children

scientific article published in September 2014

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

scientific article

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients

scientific article

Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety

scientific article published on 01 January 2009

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

scientific article

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

scientific article published on 18 March 2013

HUME: large-scale detection of causal genetic factors of adverse drug reactions

scientific article published on 01 December 2018

Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study

scientific article published on 20 July 2016

Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children

scientific article published on 19 March 2015

Hearing loss in Mexican children treated with cisplatin

scientific article published on 16 June 2014

High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada

scientific article published on 05 April 2013

Identifying persons with treated asthma using administrative data via latent class modelling

scientific article

Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy.

scientific article published on 27 April 2017

Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.

scientific article published on 21 March 2011

In Reply: Controversies on the Use of Glaucoma Medications During Surgery

scientific article published on 01 December 2018

Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study

scientific article published on 01 February 1991

Integrating Personalized Medicine in the Canadian Environment: Efforts Facilitating Oncology Clinical Research

scientific article published on 14 November 2015

Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.

scientific article published on March 2004

Medication errors: neonates, infants and children are the most vulnerable!

scientific article published on April 2008

Method for evaluating drip-rate accuracy of intravenous flow-regulating devices

scientific article published on November 1, 1991

More codeine fatalities after tonsillectomy in North American children

scientific article published on 9 April 2012

New Ways of Detecting ADRs in Neonates and Children

scientific article published on 31 August 2015

Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study

scientific article published on 14 March 2008

Oral Fluoroquinolone Prescribing to Children in the United States From 2006 to 2015

scientific article published on 01 March 2019

Oral fluoroquinolones and risk of fibromyalgia

scientific article published on 14 October 2018

Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study

scientific article

Oral morphine dosing predictions based on single dose in healthy children undergoing surgery

scientific article published on 25 October 2016

Paediatric adverse drug reaction reporting: understanding and future directions.

scientific article published on 12 February 2007

Pharmacogenetic Testing: Time for Clinical Practice Guidelines

scientific article published on April 20, 2011

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

scientific article

Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study

scientific article

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.

scientific article

Pharmacogenomic diversity in Singaporean populations and Europeans

scientific article

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer.

scientific article published on 19 March 2017

Pharmacogenomics and active surveillance for serious adverse drug reactions in children.

scientific article published on September 2010

Pharmacogenomics and adverse drug reactions in children.

scientific article published on 16 April 2014

Pharmacogenomics and its implications for autoimmune disease

scientific article published on 01 March 2007

Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine

scientific article

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.

scientific article

Pharmacogenomics of serious adverse drug reactions in pediatric oncology.

scientific article published on 21 March 2011

Phenotype standardization for immune-mediated drug-induced skin injury.

scientific article published on 11 May 2011

Physician Variability in Treating Pain and Irritability of Unknown Origin in Children with Severe Neurological Impairment ⬇️

scientific article published on July 24, 2013

Physician and parent barriers to the use of oral corticosteroids for the prevention of paediatric URTI-induced acute asthma exacerbations at home

scientific article published on 5 May 2017

Post-renal transplant erythrocytosis: a case report

scientific article published on 22 November 2014

Postpartum Maternal Codeine Therapy and the Risk of Adverse Neonatal Outcomes

scientific article published on 01 August 2012

Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.

scientific article published on 7 March 2012

Predictive genotype

scientific article published on May 2010

Prescription drug dispensing profiles for one million children: a population-based analysis ⬇️

scientific article published on July 12, 2012

Quantifying adverse drug events : are systematic reviews the answer?

scientific article published in January 2004

Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium

scientific article published on 22 June 2017

Recognizing idiosyncratic adverse drug reactions in children: A practice imperative

scientific article published on April 2001

Recommendations for HLA-B15:02 and HLA-A31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.

scientific article

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

scientific article published on 16 May 2016

Reducing anthracycline-induced cardiotoxicity through pharmacogenetics

scientific article published on 14 September 2018

Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".

scientific article published on 22 April 2014

Response to The routine use of oral steroids in paediatric asthma is not routine

scientific article published on 07 April 2018

Risk of Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine: Evidence From a Health-Claim Database

scientific article published on 28 March 2018

Risk of Extrapyramidal Adverse Events With Aripiprazole

scientific article

Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.

scientific article published on 07 December 2016

Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration

scientific article published on 14 December 2015

Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration

scientific article published on 16 April 2016

Risk of hair loss with different antidepressants

scientific article published on 01 January 2018

Risk of sensorineural hearing loss with macrolide antibiotics: A nested case-control study.

scientific article published on 06 August 2016

Risperidone Use and Risk for Gynecomastia in Men

scientific article published on 01 October 2014

Risperidone and Risk of Gynecomastia in Young Men.

scientific article

Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.

scientific article published on 5 November 2013

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

scientific article published in January 2018

Sildenafil citrate therapy for severe early-onset intrauterine growth restriction.

scientific article published in April 2011

Simple approach to dosage adjustment in patients with renal impairment ⬇️

scientific article published on November 1, 1997

Spurious rise in total carbon dioxide and chloride with negative anion gap after cystogram

scientific article published on 01 June 1995

Statin medications and the risk of gynecomastia

scientific article published on 15 July 2018

Strengths and weaknesses of using conferencing technologies to support drug policy knowledge exchange

scientific article published on 01 January 2011

Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient.

scientific article

Suspected opioid overdose case resolved by CYP2D6 genotyping

scientific article published in April 2012

Technology Enabled Knowledge Exchange: Development of a Conceptual Framework

article

Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study

scientific article published on 13 January 2015

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology

scientific article published on July 2010

The added burden of comorbidity in patients with asthma

scientific article published in December 2009

The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study

scientific article published on March 21, 2011

The comorbidity burden of the treated asthma patient population in British Columbia

scientific article published in March 2010

The emerging era of pharmacogenomics: current successes, future potential, and challenges

scientific article published on 09 May 2014

The global spectrum of protein-coding pharmacogenomic diversity.

scientific article published on 25 October 2016

The incidence of symptomatic osteonecrosis after allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia - controversy on dexamethasone as a risk factor

scientific article published on 08 November 2018

The influence of genetic variation on late toxicities in childhood cancer survivors: A review

scientific article published on 12 April 2018

The pharmacogenetics of codeine pain relief in the postpartum period.

scientific article published on 10 March 2015

The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.

scientific article published on 10 January 2013

The use of long-acting β2- agonists as monotherapy in children and adults

scientific article published on 23 January 2013

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.

scientific article

Thiazolidinediones and fractures in men and women

scientific article published in August 2009

Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces

scientific article published in March 2008

Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases

scientific article published on 27 September 2018

Use of oseltamivir in children

scientific article

Use of pharmacogenomics in pediatric renal transplant recipients

scientific article

Using pharmacogenetics to understand adverse drug reactions in children ⬇️

scientific article published on November 1, 2011

VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.

scientific article published on 29 January 2014

List of works by Bruce C Carleton

A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose

A case study examining the impacts of conferencing technologies in distributed healthcare groups

A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

A simpler approach to pharmacokinetic dosage adjustments.

A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children

Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial

Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.

Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database

Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review

Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study.

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia

Application of principal component analysis to pharmacogenomic studies in Canada

Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.

Association between regulatory advisories and codeine prescribing to postpartum women

Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study

Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema

Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery

Asthma in British Columbia: Are we finally breathing easier? A population-based study of the burden of disease over 14 years.

Beta-blocker use and COPD mortality: a systematic review and meta-analysis

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.

Camouflaged sampling and contacting of people from administrative databases: reaching target patients without knowing who they are.

Cancer pharmacogenomics in children: research initiatives and progress to date.

Cases: Cocaine adulterant linked to neutropenia

Central Nervous System Depression of Neonates Breastfed by Mothers Receiving Oxycodone for Postpartum Analgesia

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy

Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Codeine-related deaths: The role of pharmacogenetics and drug interactions

Comment: cost of rhDNase in cystic fibrosis

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.

Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS)

Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.

Dentists’ Prescribing of Analgesics for Children in British Columbia, Canada

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study

Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations

Development of a broad-based ADME panel for use in pharmacogenomic studies

Diagnostic testing for vaccinomics: is the regulatory approval framework adequate? A comparison of Canada, the United States, and Europe

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

Drug and poison information resources on the Internet, Part 1: An introduction

Drug formulary decision-making in two regional health authorities in British Columbia, Canada

Economic impact of a genetic test for cisplatin-induced ototoxicity

Effects and ethics of sanctions on childhood immunization rates

Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy

Emergency department visits for children with acute asthma: discharge instructions, parental plans, and follow-through of care--a prospective study.

Evidence-Based Pharmacotherapy: Review of Basic Concepts and Applications in Clinical Practice

Exome sequencing pilot study in children with carbamazepine-induced serious skin reactions

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.

Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources?

Fluoroquinolone Use and Risk of Carpal Tunnel Syndrome: A Pharmacoepidemiologic Study

Formulas containing live probiotic bacteria

From professional advocacy to patient advocacy: a gambit for pharmacists

Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients

Gene-based warfaring dosing

Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review

Genetic determinants of cocaine-associated agranulocytosis.

Genetic determinants of ototoxicity during and after childhood cancer treatment: design of PanCareLIFE studies (Preprint)

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

Genetic markers of cisplatin-induced hearing loss in children

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients

Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety

Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

HUME: large-scale detection of causal genetic factors of adverse drug reactions

Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study

Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children

Hearing loss in Mexican children treated with cisplatin

High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada

Identifying persons with treated asthma using administrative data via latent class modelling

Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy.

Improving pediatric drug safety: need for more efficient clinical translation of pharmacovigilance knowledge.

Recommendations for HLA-B15:02 and HLA-A31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.